A major water system eliminated recurring pathogens in four days
Bioload fell from 600 to 0 cfu/g across every test point after years of failed chemical dosing. Legionella was eliminated, confirmed by a UKAS-accredited laboratory.
Decentralised water treatment solutions treat water on site, at or near the point of use, rather than relying on a distant central plant and its network. They deliver reliable, clean, pathogen-free water where the public supply is unreliable or absent, cutting dependence on imported water and proving every result independently.
Across much of the world, the things clinical care and accreditation depend on, clean water and reliable power, cannot be assumed, and a distant central plant is not the answer.
The basics are often absent. Only about 51% of sub-Saharan primary facilities have basic water and sanitation, and only around a third have reliable electricity. A hospital cannot control infection or hold accreditation without them, and a central network that does not reach the site cannot deliver them.
The demand sits on top of a vast gap. Sub-Saharan Africa alone needs around 6,200 new facilities and roughly 2.5 million additional beds by 2030, against a projected shortfall of 6.1 million healthcare workers. Capacity has to be built where the supply is weakest.
Investment is conditional. Development finance is tied to standards such as the IFC Performance Standards on pollution prevention and community health, and international accreditation, the quality signal that attracts patients, is scarce across the region. Miss the standard and the funding does not follow.
We engineer reliable clean water treatment into the facility itself rather than depending on a central plant and its network, so the result arrives where it is needed and holds.
Water is treated on site to bring waterborne pathogens down and keep them down, with the pipework itself cleaned through so resistant pathogens lose the environment they survive in, rather than rebounding between chemical shocks. Energy is recovered and generated on site to reduce dependence on an unreliable grid, so treatment and clinical spaces keep running.
Every result is verified by an independent or accredited laboratory, and the facility is built to the international standards that financing and accreditation require, with one accountable partner carrying both the technical and the local delivery. So it stands up to an accreditation review, a financing condition or an audit.
Water treatment validated to bring waterborne pathogens to 0 cfu/g, confirmed by a UKAS-accredited laboratory, so clinical care does not depend on an unreliable or absent public supply.
The distribution system itself is cleaned through at source rather than masked, taking away the sheltered conditions where resistant pathogens survive and networks foul.
Infection control effective against antimicrobial-resistant organisms, where pathogen load is high and a reliable central supply cannot be assumed.
Energy recovered and generated on site, reducing dependence on an unreliable grid and on imported water from distant sources, so treatment and wards keep running.
Built to the IFC Performance Standards on pollution prevention and community health that development finance requires, with a single accountable partner carrying technical and local delivery.
Recover and reuse treated water on site rather than depending on a distant network, reducing demand on scarce freshwater and the cost of importing water from far away.
Independently verified, in the conditions that decide whether water can be trusted.
The questions investors and ministries ask first are the right ones: will it actually deliver clean water on site, is it sustainable for us, and does it meet the standards that finance depends on?
So we build the answer into the facility. Reliable clean water treatment, infection control effective against resistant pathogens and on-site energy are engineered in from the start, not retrofitted, and a single accountable partner carries both the technical and the local delivery. Every result is verified by an independent or accredited laboratory, and the facility is built to the IFC Performance Standards that financing requires. We start with the site or the standard under the most pressure and prove the route before you commit at scale.
They treat water on site, at or near the point of use, rather than relying on a distant central plant and its network. They deliver reliable, clean, pathogen-free water where the public supply is unreliable or absent, and the strongest also clean the network through at source and recover energy on site.
A central plant treats water at one large site and moves it through long networks. Decentralised treatment cleans water close to where it is used, so it can reach sites the network does not, without depending on a supply that may not arrive reliably.
Yes. That is the point of it. Reliable clean water treatment is built into the facility so clinical care and accreditation do not depend on a public supply that may not be reliable, in a region where only about 51% of sub-Saharan primary facilities have basic water and sanitation.
Yes. It is effective against antimicrobial-resistant organisms, with waterborne pathogens eliminated to 0 cfu/g and every sample point returned from fail to pass under accredited testing.
Yes. Treated to the right standard, water can be recovered and reused on site rather than depending on a distant network, reducing demand on scarce freshwater and the cost of importing water from far away.
Yes. Facilities are built to the IFC Performance Standards on pollution prevention and community health that development finance is conditional on, supporting bankability, with a single accountable partner carrying technical and local delivery.
Every result is verified by an independent or accredited laboratory. Waterborne pathogens were brought to 0 cfu/g under a UKAS-accredited laboratory, and 1.6 million litres were returned to zero Legionella, E. coli and coliforms over a ten-week trial verified by an independent water-authority laboratory.
Tell us the water supply gap, the infection-control goal or the financing standard you are facing. We will set out the route, in confidence, before you commit at scale.
Tell us the cost, the risk or the obligation you are facing. A senior member of our team will respond, in confidence, with how we would help.